北美人类微生物组市场到 2025 年 - 按产品(益生菌、食品、益生元、医用食品、诊断设备、药物和补充剂)、疾病(肥胖、糖尿病、自身免疫性疾病、癌症、精神障碍等)进行区域分析和预测、应用(治疗和诊断)和国家

Historic Data: 2015-2016   |   Base Year: 2017   |   Forecast Period: 2018-2025


No. of Pages: 152    |    Report Code: TIPRE00003319    |    Category: Life Sciences

North America Human Microbiome Market

北美人类微生物组市场预计将从 2017 年的 113.88 美元增至 2025 年的 4.4639 亿美元。预计 2018-2025 年该市场将以 21.5% 的复合年增长率增长。



生活方式疾病发病率的增加、对人类微生物组疗法的日益关注以及人类微生物组和下一代技术的不断进步等因素推动了市场的增长测序。然而,严格的政府指导方针以及缺乏知识和详细检查可能会对未来几年市场的增长产生负面影响。

人类从来都不是孤独的,因为它们与生活在人类体内和体表的多种微生物共存。最近的研究非常清楚地表明,这个微生物群落本质上是身体的另一个器官,在人类生理和疾病中发挥着至关重要的作用。一些基础和转化研究工作已经启动,重点是破译微生物组功能的机制及其如何有益于人类健康。许多人类疾病(如炎症性肠病和肥胖)与肠道微生物群落的组成密切相关或被认为受其影响(哮喘和糖尿病)。人们采取了许多努力来改变肠道微生物组以根除多种疾病。益生菌、益生元膳食补充剂和含有活微生物的食品已经过彻底研究,以评估它们对人类健康的影响。

美国国立卫生研究院的人类微生物组项目和相关国际努力正在定义正常微生物组的种类,研究微生物组的变化如何与疾病。包括美国人类微生物组项目在内的大型政府研究计划加速了人类微生物组的研究。

此外,许多公司正在设计和开发许多微生物组疗法。例如,Rebiotix Inc.开发了微生物群恢复疗法(MRT)药物平台,该平台可将健康的、活的、人源微生物输送到病人的肠道中以治疗疾病。因此,对人类微生物组治疗的日益关注是未来几年推动人类微生物组市场增长的主要因素。

预计美国将引领人类微生物组的采用整个北美地区在预测期内。人体微生物组的应用有益于癌症、炎症性肠病(IBD)、糖尿病、自身免疫性疾病等多个治疗领域。具体而言,人类微生物组的应用在心血管疾病、癌症、自身免疫性疾病、神经系统疾病等多种疾病和病症的发展中发挥着重要作用。因此,该国正在组织各种计划,以提高人们对益生菌和益生元的认识,以增强人体微生物组。

例如,2018 年 2 月,第三届Kisaco Research 在圣地亚哥举办了一年一度的北美微生物组大会,重点讨论了肠道、肺、口腔、皮肤和阴道等 5 个微生物组领域,并提供了有关微生物组研究、临床试验和合作伙伴关系的最新见解。

因此,由于上述因素,人类微生物组市场在未来的预测年内可能会以显着的速度增长。

图表:墨西哥人类微生物组市场收入和预测至 2027 年(十亿美元)



北美人类微生物组 - 市场细分


按产品


•益生菌
•食品
•益生元
•药用食品
•诊断装置
•毒品
•补充剂

北美人类微生物组 - 市场细分


按疾病分类


•肥胖
•糖尿病
•自身免疫性疾病
•癌症
•精神障碍
•其他

北美人类微生物组-市场细分


按应用


•治疗学
•诊断

按国家/地区


•美国
•加拿大
•墨西哥

提及的公司


• Enterome
• MicroBiome Therapeutics, LLC
• Rebiotix Inc.
•养乐多本社株式会社
• Osel Inc.
•韦丹塔生物科学公司
•元生物组学公司
•合成生物制剂公司
•杜邦
• BiomX 有限公司

North America Human Microbiome Strategic Insights

Strategic insights for North America Human Microbiome involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/north-america-human-microbiome-market-strategic-framework.webp
Get more information on this report

North America Human Microbiome Report Scope

Report Attribute Details
Market size in 2017 US$ 113.88 Million
Market Size by 2025 US$ 446.39 Million
Global CAGR (2018 - 2025) 21.5%
Historical Data 2015-2016
Forecast period 2018-2025
Segments Covered By 产品
  • 益生菌
  • 食品
  • 益生元
  • 医疗食品
  • 诊断设备
  • 药物
  • 补充剂
By 疾病
  • 肥胖症
  • 糖尿病
  • 自身免疫性疾病
  • 癌症
  • 精神障碍
By 应用
  • 治疗学
  • 诊断学
Regions and Countries Covered 北美
  • 美国
  • 加拿大
  • 墨西哥
Market leaders and key company profiles
  • Enterome
  • MicroBiome Therapeutics, LLC
  • Rebiotix Inc.
  • Yakult Honsha Co., Ltd.
  • Osel Inc.
  • Vedanta Biosciences, Inc.
  • Metabiomics Corporate
  • Synthetic Biologics, Inc.
  • DuPont
  • BiomX Ltd.
  • Get more information on this report

    North America Human Microbiome Regional Insights

    The regional scope of North America Human Microbiome refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/north-america-human-microbiome-market-geography.webp
    Get more information on this report

    The List of Companies - North America Human Microbiome Market

    The List of Companies

    1. Enterome
    2. MicroBiome Therapeutics, LLC
    3. Rebiotix Inc.
    4. Yakult Honsha Co., Ltd.
    5. Osel Inc.
    6. Vedanta Biosciences, Inc.
    7. Metabiomics Corporate
    8. Synthetic Biologics, Inc.
    9. DuPont
    10. BiomX Ltd.
    Frequently Asked Questions
    How big is the North America Human Microbiome Market?

    The North America Human Microbiome Market is valued at US$ 113.88 Million in 2017, it is projected to reach US$ 446.39 Million by 2025.

    What is the CAGR for North America Human Microbiome Market by (2018 - 2025)?

    As per our report North America Human Microbiome Market, the market size is valued at US$ 113.88 Million in 2017, projecting it to reach US$ 446.39 Million by 2025. This translates to a CAGR of approximately 21.5% during the forecast period.

    What segments are covered in this report?

    The North America Human Microbiome Market report typically cover these key segments-

  • 产品 (益生菌, 食品, 益生元, 医疗食品, 诊断设备, 药物, 补充剂)
  • 疾病 (肥胖症, 糖尿病, 自身免疫性疾病, 癌症, 精神障碍)
  • 应用 (治疗学, 诊断学)
  • What is the historic period, base year, and forecast period taken for North America Human Microbiome Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Human Microbiome Market report:

  • Historic Period : 2015-2016
  • Base Year : 2017
  • Forecast Period : 2018-2025
  • Who are the major players in North America Human Microbiome Market?

    The North America Human Microbiome Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Enterome
  • MicroBiome Therapeutics, LLC
  • Rebiotix Inc.
  • Yakult Honsha Co., Ltd.
  • Osel Inc.
  • Vedanta Biosciences, Inc.
  • Metabiomics Corporate
  • Synthetic Biologics, Inc.
  • DuPont
  • BiomX Ltd.
  • Who should buy this report?

    The North America Human Microbiome Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the North America Human Microbiome Market value chain can benefit from the information contained in a comprehensive market report.